Join
Live feed
·
INSIDERFilingvia Quantisnow
Zivo Bioscience Inc. logo

President and CEO Payne John Bernard bought $99,995 worth of shares (11,709 units at $8.54), increasing direct ownership by 148% to 19,618 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ZIVO· Zivo Bioscience Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZIVO (Zivo Bioscience Inc.) and more on Quantisnow.